There is no specific time course of treatment for Vinaclat, all of which need to be taken for a long period of time to guide the new progress of the disease.
Vinaclat belongs to the BCL-2 inhibitor class of targeted therapeutic drugs, mainly used in chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) treatment, there is no specific time course of treatment limit, are required to take medication for a long time, until the condition of the emergence of new advances need to be suspended, replacement of the targeted drug or treatment plan.
After entering the human body, Vinacrine can effectively inhibit the function and activity of BCL-2, replace BNM and other pro-apoptosis, activate cysteine protease and enhance the role of mitochondrial outer membrane permeability, thus restoring the original apoptosis and stabilizing the patient’s condition.
Please strictly follow the doctor’s instructions for drug treatment, do not self-medicate.